TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Scanfarma AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
6,703
|
6,938
|
8,481 |
| Financial expenses |
4
|
1
|
1 |
| Earnings before taxes |
504
|
373
|
-132 |
| EBITDA |
483
|
372
|
-131 |
| Total assets |
5,048
|
5,346
|
5,479 |
| Current assets |
4,876
|
5,346
|
5,479 |
| Current liabilities |
590
|
974
|
1,038 |
| Equity capital |
3,093
|
2,758
|
2,671 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
5
|
6
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
61.3%
|
51.6%
|
48.7% |
| Turnover per employee |
1,341
|
1,156
|
1,212 |
| Profit as a percentage of turnover |
7.5%
|
5.4%
|
-1.6% |
| Return on assets (ROA) |
10.1%
|
7.0%
|
-2.4% |
| Current ratio |
826.4%
|
548.9%
|
527.8% |
| Return on equity (ROE) |
16.3%
|
13.5%
|
-4.9% |
| Change turnover |
-270
|
-857
|
-339 |
| Change turnover % |
-4%
|
-11%
|
-4% |
| Chg. No. of employees |
-1
|
-1
|
-1 |
| Chg. No. of employees % |
-17%
|
-14%
|
-13% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.